Create a Free Account
or
Create a Free Account
or
| # | Filing Date | Period End Date | Type | Report Link |
|---|---|---|---|---|
| No Data found | ||||
| # | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
|---|
Mizuho analyst Ann Hynes maintains Elevance Health (NYSE:ELV) with a Buy and raises the price target from $575 to $585.
Last week's top performers included United Airlines, Bentley Systems, Progressive Corp and Morgan Stanley.
RBC Capital analyst Ben Hendrix maintains Elevance Health (NYSE:ELV) with a Outperform and raises the price target from $574...
UBS analyst A.J. Rice maintains Elevance Health (NYSE:ELV) with a Buy and raises the price target from $585 to $605.
Wells Fargo analyst Stephen Baxter maintains Elevance Health (NYSE:ELV) with a Overweight and raises the price target from $...
